
Cells Organize Themselves into ‘Neighborhoods’ That Could Shape Treatment
“Cell atlases” offer an unprecedented look at how kidney cells become diseased and how fetal cells invade and remodel the placenta’s blood vessels
Heidi Ledford works for Nature magazine.
“Cell atlases” offer an unprecedented look at how kidney cells become diseased and how fetal cells invade and remodel the placenta’s blood vessels
A link between endometriosis and bacterial infection suggests a potential way to treat the painful disorder
Fatlike compounds in ancient rocks point to a vast array of previously unknown microbes that once dominated complex life on Earth
Key genes that are active in the brains of older people are also active in the brains of people who developed serious COVID
The “most complicated therapy ever” tailors bespoke, genome-edited immune cells to attack tumors
Under Elon Musk’s leadership, extremists could flock back to Twitter under the guise of “free speech,” and researchers are gearing up to study their impact
A cellular version of the computer game challenges assumptions about intelligence
Cases of paralysis in the U.S. and Israel suggest vaccine-derived poliovirus has infected many people
Two years into the pandemic, the COVID-19 drugs pipeline is primed to pump out novel treatments—and fresh uses for familiar therapies.
Researchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms
A rapidly spreading variant could dangerously strain health-care systems, even if the severe disease risk is relatively low for an individual
With vaccination campaigns underway in some countries while others weigh the options, Nature looks at the evidence for vaccinating younger people
At a pivotal moment in the pandemic, Nature explores key questions about the vaccines that countries are racing to deliver while viral variants spread around the globe
People older than 80 who waited 11 to 12 weeks for their second jab had higher peak antibody levels than did those who waited only three weeks
Preliminary results suggest the vaccine is up to 77 percent effective in young children, but researchers await larger studies
Researchers are searching for possible links between unusual clotting and the Oxford-AstraZeneca coronavirus vaccine
Organoids made of tear-producing cells offer chances to study, and possibly treat, eye disorders
Uptake by patients and physicians has been low in the U.S. even though some therapies have been authorized for months
Two RNA vaccines will be useful as U.S. infections surge, but the speedy authorizations complicate clinical trials
Despite conflicting data, the highly anticipated results will make the treatment a standard of care in the U.S.
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account